Condition
Locally Recurrent Head and Neck Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Locally Recurrent Head and Neck Squamous Cell Carcinoma clinical trials that are recruiting, in United States. By phase: Phase 2 (2), Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Locally Recurrent Head and Neck Squamous Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Adding chemotherapy or chemo-immunotherapy to standard salvage surgery for advanced head and neck cancer | Phase 2 | Tucson, Arizona and 114 other locations | Recruiting | Sep 29, 2025 |
| Combination treatment for recurrent head and neck cancer | Phase 1 | Sacramento, California and 1 other locations | Recruiting | Jan 18, 2024 |
| Combining cabozantinib and nivolumab to treat advanced melanoma and head and neck cancer | Phase 2 | Phoenix, Arizona and 231 other locations | Recruiting | Nov 29, 2021 |
| Combining immunotherapy and radiation for recurrent head and neck cancer | Phase 1 | Columbus, Ohio | Recruiting | Feb 15, 2021 |
All recruiting trials (4)
-
Adding chemotherapy or chemo-immunotherapy to standard salvage surgery for advanced head and neck cancer
This trial tests whether giving chemotherapy alone or chemotherapy plus the immunotherapy cemiplimab before salvage surgery helps people with PD-L1–positive recurrent or persistent head and neck squamous cell carcinoma.
-
Combination treatment for recurrent head and neck cancer
This study is testing a new combination of medications and radiation to see if it helps people with tough-to-treat head and neck cancer feel better and live longer.
-
Combining cabozantinib and nivolumab to treat advanced melanoma and head and neck cancer
This study is testing a combination of two cancer drugs, cabozantinib and nivolumab, to see if they can help people with advanced melanoma or head and neck cancer while also looking at how to better match treatments to patients based on their tumor characteristics.
-
Combining immunotherapy and radiation for recurrent head and neck cancer
This study is testing if combining a new immune treatment with radiation can help people with recurrent head and neck cancer feel better and live longer.
Related topics
Quick answers
How many Locally Recurrent Head and Neck Squamous Cell Carcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.